公开(公告)号：US20120129923A1

公开(公告)日：2012-05-24

申请号：US13382704

申请日：2009-10-30

Applicant: Anil Kumar Kruthiventi ,  Iqbal Javed ,  Satyanarayana Reddy Jaggavarapu ,  RaviKumar Nagalapalli ,  Ganesh Saraswatula Viswanadha ,  Solomon Kamalakaran Anand

Inventor： Anil Kumar Kruthiventi ,  Iqbal Javed ,  Satyanarayana Reddy Jaggavarapu ,  RaviKumar Nagalapalli ,  Ganesh Saraswatula Viswanadha ,  Solomon Kamalakaran Anand

IPC: A61K31/352 ,  A61P3/00 ,  A61P3/10 ,  C07D311/30

CPC classification number: A61K31/4965 ,  A61K31/155 ,  A61K31/352 ,  A61K31/4015 ,  A61K31/4439 ,  A61K31/445 ,  A61K31/55 ,  A61K45/06 ,  A61K2300/00

Abstract: Disclosed herein is synergistic pharmaceutical co-crystals composition comprising Quercetin and an antidiabetic agent(s) as combination drug that have unique physical properties and biological activity which differ from the active agent in pure form. The invention further discloses process for preparation of the same and pharmaceutical compositions comprising these synergistic co-crystals.

Abstract translation: 本文公开了包含槲皮素和抗糖尿病剂作为组合药物的协同药用共晶组合物，其具有与纯形式的活性剂不同的独特的物理性质和生物活性。 本发明还公开了其制备方法和包含这些协同共晶体的药物组合物。